Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-033045
Filing Date
2022-10-05
Accepted
2022-10-05 18:21:41
Documents
2
Period of Report
2022-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1675
2 EX-24 DOCUMENT attachment1.htm EX-24 3609
  Complete submission text file 0000899243-22-033045.txt   6608
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3023 MONTBRETIA WAY SAN RAMON CA 94582
Business Address
Eizen Joshua M (Reporting) CIK: 0001949621 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41331 | Film No.: 221296691